Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Nucl Med Mol Imaging ; 51(3): 681-690, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37843599

RESUMEN

PURPOSE: There is a need for early quantitative markers of potential treatment response in patients with hereditary transthyretin (ATTRv) amyloidosis to guide therapy. This study aims to evaluate changes in cardiac tracer uptake on bone scintigraphy in ATTRv amyloidosis patients on different treatments. METHODS: In this retrospective cohort study, outcomes of 20 patients treated with the transthyretin (TTR) gene silencer patisiran were compared to 12 patients treated with a TTR-stabilizer. Changes in NYHA class, cardiac biomarkers in serum, wall thickness, and diastolic parameters on echocardiography and NYHA class during treatment were evaluated. RESULTS: Median heart/whole-body (H/WB) ratio on bone scintigraphy decreased from 4.84 [4.00 to 5.31] to 4.16 [3.66 to 4.81] (p < .001) in patients treated with patisiran for 29 [15-34] months. No changes in the other follow-up parameters were observed. In patients treated with a TTR-stabilizer for 24 [20 to 30] months, H/WB ratio increased from 4.46 [3.24 to 5.13] to 4.96 [ 3.39 to 5.80] (p = .010), and troponin T increased from 19.5 [9.3 to 34.0] ng/L to 20.0 [11.8 to 47.8] ng/L (p = .025). All other parameters did not change during treatment with a TTR-stabilizer. CONCLUSION: A change in cardiac tracer uptake on bone scintigraphy may be an early marker of treatment-specific response or disease progression in ATTRv amyloidosis patients.


Asunto(s)
Neuropatías Amiloides Familiares , Cardiomiopatías , Humanos , Prealbúmina/genética , Estudios Retrospectivos , Estudios de Seguimiento , Neuropatías Amiloides Familiares/diagnóstico por imagen , Cintigrafía , Cardiomiopatías/diagnóstico por imagen
2.
Neth J Med ; 61(5): 180-1, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12916547

RESUMEN

Low serum potassium concentration is a frequently encountered abnormality, seldom accompanied by life-threatening symptoms. We present a 55-year-old women with a severe, symptomatic hypokalaemia. The pathogenesis and clinical manifestations are discussed.


Asunto(s)
Cabeza/fisiopatología , Hipopotasemia/diagnóstico , Hipopotasemia/fisiopatología , Postura/fisiología , Femenino , Humanos , Hipopotasemia/terapia , Persona de Mediana Edad
4.
Neth J Med ; 60(10): 414-5, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12607594

RESUMEN

A 19-year-old woman is presented with high-spiking fever, pericardial tamponade and respiratory failure. A diagnosis of adult onset Still's disease was made. This is a rare inflammatory disease with an unknown aetiology. The diagnosis is made by exclusion and with the help of diagnostic criteria. Treatment with corticosteroids met with a good response.


Asunto(s)
Fiebre/diagnóstico , Derrame Pericárdico/diagnóstico , Corticoesteroides/uso terapéutico , Adulto , Diagnóstico Diferencial , Femenino , Fiebre/tratamiento farmacológico , Humanos , Derrame Pericárdico/tratamiento farmacológico , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/tratamiento farmacológico , Enfermedad de Still del Adulto/diagnóstico , Enfermedad de Still del Adulto/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...